Qpharm Inc.

2 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• DIETARYLBL1 refused line

  Not identified as a dietary supplement

  The label appeared not to identify the product with the term "dietary supplement" (which may be modified with the name of an ingredient).

• DIRSEXMPT1 refused line

  DIRSEXMPT

• LACKS FIRM1 refused line

  Manufacturer name and address missing

  The packaged product's label appeared not to show the name and place of business of the manufacturer, packer, or distributor.

• LACKS N/C1 refused line

  Net quantity statement missing

  The packaged food appeared not to carry an accurate statement of the quantity of contents, such as net weight, measure, or count, on its label.

• LIST INGRE1 refused line

  Ingredients not listed

  The product is made from two or more ingredients and the label appeared not to list the common or usual name of each one (or, for a juice beverage, the percentage of juice).

• NCONTACT1 refused line

  No U.S. adverse event contact on supplement label

  The dietary supplement label appeared not to show a U.S. address or phone number through which a serious adverse event can be reported.

• NUTRIT LBL1 refused line

  Nutrition information missing from label

  The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.

• UNAPPROVED1 refused line

  Unapproved new drug

  The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

Questions about Qpharm Inc.

Is Qpharm Inc. on an FDA import alert?

Yes. As of October 26, 2026, Qpharm Inc. is on the red list of FDA Import Alert 99-39, “Imported foods that appear to be misbranded”, for health supplement rhoziva; FDA published the listing on August 11, 2017.

Has FDA refused shipments from Qpharm Inc.?

Yes. FDA refused 1 shipment line from Qpharm Inc. on August 24, 2017. The most recent, on August 24, 2017, was herbals & botanicals (not teas), n.e.c., charged as LIST INGRE (ingredients not listed).

Why did FDA refuse Qpharm Inc.'s shipments?

The most frequent charges are DIETARYLBL (not identified as a dietary supplement, 1 line) and DIRSEXMPT (dirsexmpt, 1 line).

What is Qpharm Inc.'s FEI number?

Qpharm Inc.'s FDA Establishment Identifier (FEI) is 3002815077.

Can shipments from Qpharm Inc. still enter the U.S.?

Shipments of health supplement rhoziva from Qpharm Inc. can be detained without physical examination under Import Alert 99-39; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).